CXCR4-Tango Citations (9)
Originally described in: PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguere PM, Sciaky N, Roth BL Nat Struct Mol Biol. 2015 May;22(5):362-9. doi: 10.1038/nsmb.3014. Epub 2015 Apr 20. PubMed Journal
Articles Citing CXCR4-Tango
| Articles |
|---|
| Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists. Eby JM, Abdelkarim H, Albee LJ, Tripathi A, Gao X, Volkman BF, Gaponenko V, Majetschak M. Mol Cell Biochem. 2017 Apr 28. doi: 10.1007/s11010-017-3044-7. PubMed |
| Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M. Open Biol. 2018 Jan;8(1). pii: rsob.170207. doi: 10.1098/rsob.170207. PubMed |
| Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by alpha1-adrenergic receptors at the heteromeric receptor complex. Gao X, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Sci Rep. 2018 Feb 9;8(1):2730. doi: 10.1038/s41598-018-21096-4. PubMed |
| Partial agonist activity of alpha1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. PLoS One. 2018 Sep 24;13(9):e0204041. doi: 10.1371/journal.pone.0204041. eCollection 2018. PubMed |
| Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and alpha1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays. Gao X, Enten GA, DeSantis AJ, Volkman BF, Gaponenko V, Majetschak M. Biochem Biophys Res Commun. 2020 Jul 23;528(2):368-375. doi: 10.1016/j.bbrc.2020.02.094. Epub 2020 Feb 19. PubMed |
| Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers. Gao X, Enten GA, DeSantis AJ, Majetschak M. FEBS Lett. 2021 Jul;595(14):1863-1875. doi: 10.1002/1873-3468.14135. Epub 2021 Jun 11. PubMed |
| Effects of Small Molecule Ligands on ACKR3 Receptors. Hopkins BE, Masuho I, Ren D, Iyamu ID, Lv W, Malik N, Martemyanov KA, Schiltz GE, Miller RJ. Mol Pharmacol. 2022 Sep;102(3):128-138. doi: 10.1124/molpharm.121.000295. Epub 2022 Jul 9. PubMed |
| LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration. Hong JM, Lee JW, Seen DS, Jeong JY, Huh WK. Cell Commun Signal. 2023 Sep 25;21(1):257. doi: 10.1186/s12964-023-01261-7. PubMed |
| GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol. Sukhtankar DD, Fung JJ, Kim MN, Cayton T, Chiou V, Caculitan NG, Zalicki P, Kim S, Jo Y, Kim S, Lee JM, Choi J, Mun S, Chin A, Jang Y, Lee JY, Kim G, Kim EH, Huh WK, Jeong JY, Seen DS, Cardarelli PM. PLoS One. 2023 Oct 25;18(10):e0287863. doi: 10.1371/journal.pone.0287863. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.